DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Goy A, Younes A, McLaughlin P. et al.
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin’s lymphoma.
J Clin Oncol 2005; 23: 667-675
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.